Elevated plasma surfactant protein d (sp-d) levels and a direct correlation with anti-severe acute respiratory syndrome coronavirus-specific igg antibody in sars patients

Scandinavian Journal of Immunology

Volumn 69, Issue 6, 2009, Pages 508-515

  Wu, Y P ^b,c   Liu, Z H ^d,e   Wei, R ^b   Pan, S D ^b   Mao, N Y ^e   Chen, B ^f   Han, J J ^b   Zhang, F S ^g   Holmskov, U ^a   Xia, Z L ^b   De Groot, P G ^c   Reid, K B M ^h   Xu, W B ^e   Sorensen, G L ^a  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b TAISHAN MEDICAL UNIVERSITY   (China)

^c UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^d INSTITUTE OF PATHOGEN BIOLOGY   (China)

^e CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^f CAPITAL MEDICAL UNIVERSITY   (China)

^g Department of Medicine   (China)

^h UNIVERSITY OF OXFORD   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; IMMUNOGLOBULIN G ANTIBODY; PLASMA PROTEIN; PLASMA SURFACTANT PROTEIN D; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ADAPTIVE IMMUNITY; ADOLESCENT; ADULT; AGED; ANTIBODY SPECIFICITY; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL TRIAL; COMMUNITY ACQUIRED PNEUMONIA; CONTROLLED STUDY; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC TEST; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; HUMAN CELL; INNATE IMMUNITY; LUNG ALVEOLUS CELL; LUNG INJURY; MALE; PATIENT MONITORING; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN DETERMINATION; REINFECTION; SARS CORONAVIRUS; SCHOOL CHILD; SEVERE ACUTE RESPIRATORY SYNDROME; STREPTOCOCCUS PNEUMONIA;

ADOLESCENT; ADULT; AGED; ANTIBODIES, VIRAL; BIOLOGICAL MARKERS; CHILD; CHILD, PRESCHOOL; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; IMMUNOGLOBULIN G; MALE; MIDDLE AGED; NUCLEOCAPSID PROTEINS; PULMONARY SURFACTANT-ASSOCIATED PROTEIN D; RECOMBINANT PROTEINS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; SARS VIRUS; SEVERE ACUTE RESPIRATORY SYNDROME;

EID: 65349193844     PISSN: 03009475     EISSN: 13653083     Source Type: Journal    
DOI: 10.1111/j.1365-3083.2009.02245.x     Document Type: Article

References (44)

1. Drosten C, Gunther S, Preiser W et al. Identification of a novel coronavirus in patients with severe acute respiratory syndrome. N Engl J Med 2003 348 : 1967 76. (Pubitemid 36569985)
2. Ksiazek TG, Erdman D, Goldsmith CS et al. A novel coronavirus associated with severe acute respiratory syndrome. N Engl J Med 2003 348 : 1953 66. (Pubitemid 36569984)
3. Peiris JS, Lai ST, Poon LL et al. Coronavirus as a possible cause of severe acute respiratory syndrome. Lancet 2003 361 : 1319 25. (Pubitemid 36514862)
4. Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev 2007 20 : 660 94. (Pubitemid 47623772)
5. Chen J, Subbarao K. The Immunobiology of SARS*. Annu Rev Immunol 2007 25 : 443 72. (Pubitemid 46697914)
6. Holmskov U, Thiel S, Jensenius JC. Collections and ficolins: humoral lectins of the innate immune defense. Annu Rev Immunol 2003 21 : 547 78. (Pubitemid 37174541)
7. Wright JR. Immunoregulatory functions of surfactant proteins. Nat Rev Immunol 2005 5 : 58 68. (Pubitemid 40070331)
8. Meschi J, Crouch EC, Skolnik P et al. Surfactant protein D binds to human immunodeficiency virus (HIV) envelope protein gp120 and inhibits HIV replication. J Gen Virol 2005 86 : 3097 107. (Pubitemid 41555576)
9. Brinker KG, Martin E, Borron P et al. Surfactant protein D enhances bacterial antigen presentation by bone marrow-derived dendritic cells. Am J Physiol Lung Cell Mol Physiol 2001 281 : L1453 63. (Pubitemid 33152145)
10. Hansen S, Lo B, Evans K, Neophytou P, Holmskov U, Wright JR. Surfactant protein D augments bacterial association but attenuates major histocompatibility complex class II presentation of bacterial antigens. Am J Respir Cell Mol Biol 2007 36 : 94 102. (Pubitemid 46067712)
11. Hartshorn KL, Crouch EC, White MR et al. Evidence for a protective role of pulmonary surfactant protein D (SP-D) against influenza A viruses. J Clin Invest 1994 94 : 311 9. (Pubitemid 24218106)
12. LeVine AM, Whitsett JA, Hartshorn KL, Crouch EC, Korfhagen TR. Surfactant protein D enhances clearance of influenza A virus from the lung in vivo. J Immunol 2001 167 : 5868 73. (Pubitemid 33062780)
13. Ip WK, Chan KH, Law HK et al. Mannose-binding lectin in severe acute respiratory syndrome coronavirus infection. J Infect Dis 2005 15 : 191. (Pubitemid 40656758)
14. Leth-Larsen R, Zhong F, Chow VT, Holmskov U, Lu J. The SARS coronavirus spike glycoprotein is selectively recognized by lung surfactant protein D and activates macrophages. Immunobiology 2007 212 : 201 11. (Pubitemid 46505956)
15. Lee N, Hui D, Wu A et al. A major outbreak of severe acute respiratory syndrome in Hong Kong. N Engl J Med 2003 348 : 1986 94. (Pubitemid 36569987)
16. Wu YP, Wei R, de Groot PG. SARS in Hong Kong. N Engl J Med 2003 349 : 708 9. (Pubitemid 36976006)
17. Ng KH, Wu AK, Cheng VC et al. Pulmonary artery thrombosis in a patient with severe acute respiratory syndrome. Postgrad Med J 2005 81 : e3.
18. Wu YP, Wei R, Liu ZH et al. Analysis of thrombotic factors in severe acute respiratory syndrome (SARS) patients. Thromb Haemost 2006 96 : 100 1. (Pubitemid 44160881)
19. Liu ZH, Wei R, Wu YP et al. Elevated plasma tissue-type plasminogen activator (t-PA) and soluble thrombomodulin in patients suffering from severe acute respiratory syndrome (SARS) as a possible index for prognosis and treatment strategy. Biomed Environ Sci 2005 18 : 260 4. (Pubitemid 41463304)
20. Eisner MD, Parsons P, Matthay MA, Ware L, Greene K. Plasma surfactant protein levels and clinical outcomes in patients with acute lung injury. Thorax 2003 58 : 983 8. (Pubitemid 37392811)
21. Sorensen GL, Husby S, Holmskov U. Surfactant protein A and surfactant protein D variation in pulmonary disease. Immunobiology 2007 212 : 381 416. (Pubitemid 46825244)
22. Greene KE, Wright JR, Steinberg KP et al. Serial changes in surfactant-associated proteins in lung and serum before and after onset of ARDS. Am J Respir Crit Care Med 1999 160 : 1843 50. (Pubitemid 30004685)
23. Endo S, Sato N, Nakae H et al. Surfactant protein A and D (SP-A, AP-D) levels in patients with septic ARDS. Res Commun Mol Pathol Pharmacol 2002 111 : 245 51. (Pubitemid 38812226)
24. Haczku A, Atochina EN, Tomer Y et al. Aspergillus fumigatus-induced allergic airway inflammation alters surfactant homeostasis and lung function in BALB/c mice. Am J Respir Cell Mol Biol 2001 25 : 45 50. (Pubitemid 32682704)
25. Krane M, Griese M. Surfactant protein D in serum from patients with allergic bronchopulmonary aspergillosis. Eur Respir J 2003 22 : 592 5. (Pubitemid 37258535)
26. Surjit M, Lal SK. The SARS-CoV nucleocapsid protein: a protein with multifarious activities. Infect Genet Evol 2008 8 : 397 405.
27. Fujimoto K, Chan KH, Takeda K, Lo KF, Leung RH, Okamoto T. Sensitive and specific enzyme-linked immunosorbent assay using chemiluminescence for detection of severe acute respiratory syndrome viral infection. J Clin Microbiol 2008 46 : 302 10.
28. World Health Organization (WHO). Severe acute respiratory syndrome (SARS). Wkly Epidemiol Rec 2003 78 : 81 3.
29. Ho PL, Chau PH, Yip PS et al. A prediction rule for clinical diagnosis of severe acute respiratory syndrome. Eur Respir J 2005 26 : 474 9. (Pubitemid 41264212)
30. Ooi CG, Khong PL, Lam B et al. Severe acute respiratory syndrome: relationship between radiologic and clinical parameters. Radiology 2003 229 : 492 9. (Pubitemid 37310837)
31. Wu HS, Chiu SC, Tseng TC et al. Serologic and molecular biologic methods for SARS-associated coronavirus infection, Taiwan. Emerg Infect Dis 2004 10 : 304 10. (Pubitemid 38176974)
32. Leth-Larsen R, Nordenbaek C, Tornoe I et al. Surfactant protein D (SP-D) serum levels in patients with community-acquired pneumonia. Clin Immunol 2003 108 : 29 37. (Pubitemid 36809213)
33. Muller MP, Tomlinson G, Marrie TJ et al. Can routine laboratory tests discriminate between severe acute respiratory syndrome and other causes of community-acquired pneumonia? Clin Infect Dis 2005 40 : 1079 86. (Pubitemid 40490229)
34. Hobo S, Niwa H, Anzai T. Evaluation of serum amyloid A and surfactant protein D in sera for identification of the clinical condition of horses with bacterial pneumonia. J Vet Med Sci 2007 69 : 827 30. (Pubitemid 47367454)
35. Hartl D, Griese M. Surfactant protein D in human lung diseases. Eur J Clin Invest 2006 36 : 423 35. (Pubitemid 43742701)
36. Fujita M, Shannon JM, Ouchi H, Voelker DR, Nakanishi Y, Mason RJ. Serum surfactant protein D is increased in acute and chronic inflammation in mice. Cytokine 2005 31 : 25 33. (Pubitemid 40828355)
37. Sin DD, Man SF, Marciniuk DD et al. The effects of fluticasone with or without salmeterol on systemic biomarkers of inflammation in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008 177 : 1207 14.
38. Cheng IW, Ware LB, Greene KE, Nuckton TJ, Eisner MD, Matthay MA. Prognostic value of surfactant proteins A and D in patients with acute lung injury. Crit Care Med 2003 31 : 20 7. (Pubitemid 36151144)
39. Che XY, Hao W, Wang Y et al. Nucleocapsid protein as early diagnostic marker for SARS. Emerg Infect Dis 2004 10 : 1947 9. (Pubitemid 39458559)
40. Woo PC, Lau SK, Wong BH et al. Differential sensitivities of severe acute respiratory syndrome (SARS) coronavirus spike polypeptide enzyme-linked immunosorbent assay (ELISA) and SARS coronavirus nucleocapsid protein ELISA for serodiagnosis of SARS coronavirus pneumonia. J Clin Microbiol 2005 43 : 3054 8. (Pubitemid 40981302)
41. Woo PC, Lau SK, Wong BH et al. False-positive results in a recombinant severe acute respiratory syndrome-associated coronavirus (SARS-CoV) nucleocapsid enzyme-linked immunosorbent assay due to HCoV-OC43 and HCoV-229E rectified by Western blotting with recombinant SARS-CoV spike polypeptide. J Clin Microbiol 2004 42 : 5885 8. (Pubitemid 39664386)
42. Sun ZF, Meng XJ. Antigenic cross-reactivity between the nucleocapsid protein of severe acute respiratory syndrome (SARS) coronavirus and polyclonal antisera of antigenic group I animal coronaviruses: implication for SARS diagnosis. J Clin Microbiol 2004 42 : 2351 2. (Pubitemid 38637885)
43. Woo PC, Lau SK, Wong BH et al. Longitudinal profile of immunoglobulin G (IgG), IgM, and IgA antibodies against the severe acute respiratory syndrome (SARS) coronavirus nucleocapsid protein in patients with pneumonia due to the SARS coronavirus. Clin Diagn Lab Immunol 2004 11 : 665 8. (Pubitemid 38943986)
44. Stockman LJ, Bellamy R, Garner P. SARS: systematic review of treatment effects. PLoS Med 2006 3 : e343. (Pubitemid 44455263)